Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia

NCT01047397 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Disease

Interventions

DRUG: 1278863A
DRUG: Placebo

Sponsor

GlaxoSmithKline